Celogics Email Format
Biotechnology ResearchWashington, United States2-10 Employees
Celogics is a biotechnology research company focused on improving human cell culture quality and advancing iPSC-derived cell products for research applications. Its offerings are aimed at drug discovery, safety screening, and disease modeling, with an emphasis on delivering high-functioning, research-use-only cells under the Celo.Cells brand. The company seeks to address limitations in traditional cellular research methods by providing more reliable human cell models for laboratory use. Headquartered in Seattle, Washington, Celogics operates as a joint venture between Curi Bio and NEXEL, and is developing a dedicated manufacturing facility to support its cell production efforts. The organization targets the life sciences and pharmaceutical research markets, aiming to serve researchers who require advanced iPSC-derived cells for a range of applications.